215 related articles for article (PubMed ID: 32125365)
1. Gene replacement ameliorates deficits in mouse and human models of cyclin-dependent kinase-like 5 disorder.
Gao Y; Irvine EE; Eleftheriadou I; Naranjo CJ; Hearn-Yeates F; Bosch L; Glegola JA; Murdoch L; Czerniak A; Meloni I; Renieri A; Kinali M; Mazarakis ND
Brain; 2020 Mar; 143(3):811-832. PubMed ID: 32125365
[TBL] [Abstract][Full Text] [Related]
2. Loss of CDKL5 in Glutamatergic Neurons Disrupts Hippocampal Microcircuitry and Leads to Memory Impairment in Mice.
Tang S; Wang IJ; Yue C; Takano H; Terzic B; Pance K; Lee JY; Cui Y; Coulter DA; Zhou Z
J Neurosci; 2017 Aug; 37(31):7420-7437. PubMed ID: 28674172
[TBL] [Abstract][Full Text] [Related]
3. The green tea polyphenol epigallocatechin-3-gallate (EGCG) restores CDKL5-dependent synaptic defects in vitro and in vivo.
Trovò L; Fuchs C; De Rosa R; Barbiero I; Tramarin M; Ciani E; Rusconi L; Kilstrup-Nielsen C
Neurobiol Dis; 2020 May; 138():104791. PubMed ID: 32032735
[TBL] [Abstract][Full Text] [Related]
4. Molecular and Synaptic Bases of CDKL5 Disorder.
Zhu YC; Xiong ZQ
Dev Neurobiol; 2019 Jan; 79(1):8-19. PubMed ID: 30246934
[TBL] [Abstract][Full Text] [Related]
5. Dendritic Spine Instability in a Mouse Model of CDKL5 Disorder Is Rescued by Insulin-like Growth Factor 1.
Della Sala G; Putignano E; Chelini G; Melani R; Calcagno E; Michele Ratto G; Amendola E; Gross CT; Giustetto M; Pizzorusso T
Biol Psychiatry; 2016 Aug; 80(4):302-311. PubMed ID: 26452614
[TBL] [Abstract][Full Text] [Related]
6. Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder.
Fuchs C; Gennaccaro L; Trazzi S; Bastianini S; Bettini S; Lo Martire V; Ren E; Medici G; Zoccoli G; Rimondini R; Ciani E
Neural Plast; 2018; 2018():9726950. PubMed ID: 29977282
[TBL] [Abstract][Full Text] [Related]
7. CDKL5 protein substitution therapy rescues neurological phenotypes of a mouse model of CDKL5 disorder.
Trazzi S; De Franceschi M; Fuchs C; Bastianini S; Viggiano R; Lupori L; Mazziotti R; Medici G; Lo Martire V; Ren E; Rimondini R; Zoccoli G; Bartesaghi R; Pizzorusso T; Ciani E
Hum Mol Genet; 2018 May; 27(9):1572-1592. PubMed ID: 29474534
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of Cdkl5 transcript isoforms in rat.
Hector RD; Dando O; Ritakari TE; Kind PC; Bailey ME; Cobb SR
Gene; 2017 Mar; 603():21-26. PubMed ID: 27940108
[TBL] [Abstract][Full Text] [Related]
9. Synaptic synthesis, dephosphorylation, and degradation: a novel paradigm for an activity-dependent neuronal control of CDKL5.
La Montanara P; Rusconi L; Locarno A; Forti L; Barbiero I; Tramarin M; Chandola C; Kilstrup-Nielsen C; Landsberger N
J Biol Chem; 2015 Feb; 290(7):4512-27. PubMed ID: 25555910
[TBL] [Abstract][Full Text] [Related]
10. CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons.
Ricciardi S; Ungaro F; Hambrock M; Rademacher N; Stefanelli G; Brambilla D; Sessa A; Magagnotti C; Bachi A; Giarda E; Verpelli C; Kilstrup-Nielsen C; Sala C; Kalscheuer VM; Broccoli V
Nat Cell Biol; 2012 Sep; 14(9):911-23. PubMed ID: 22922712
[TBL] [Abstract][Full Text] [Related]
11. A GABA
Gennaccaro L; Fuchs C; Loi M; Roncacè V; Trazzi S; Ait-Bali Y; Galvani G; Berardi AC; Medici G; Tassinari M; Ren E; Rimondini R; Giustetto M; Aicardi G; Ciani E
Neurobiol Dis; 2021 Jun; 153():105304. PubMed ID: 33621640
[TBL] [Abstract][Full Text] [Related]
12. Abnormalities of mitochondrial dynamics and bioenergetics in neuronal cells from CDKL5 deficiency disorder.
Van Bergen NJ; Massey S; Stait T; Ellery M; Reljić B; Formosa LE; Quigley A; Dottori M; Thorburn D; Stroud DA; Christodoulou J
Neurobiol Dis; 2021 Jul; 155():105370. PubMed ID: 33905871
[TBL] [Abstract][Full Text] [Related]
13. Biochemical and anatomical evidence for specialized voltage-dependent calcium channel gamma isoform expression in the epileptic and ataxic mouse, stargazer.
Sharp AH; Black JL; Dubel SJ; Sundarraj S; Shen JP; Yunker AM; Copeland TD; McEnery MW
Neuroscience; 2001; 105(3):599-617. PubMed ID: 11516827
[TBL] [Abstract][Full Text] [Related]
14. Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder.
Medici G; Tassinari M; Galvani G; Bastianini S; Gennaccaro L; Loi M; Mottolese N; Alvente S; Berteotti C; Sagona G; Lupori L; Candini G; Baggett HR; Zoccoli G; Giustetto M; Muotri A; Pizzorusso T; Nakai H; Trazzi S; Ciani E
Neurotherapeutics; 2022 Oct; 19(6):1886-1904. PubMed ID: 36109452
[TBL] [Abstract][Full Text] [Related]
15. The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
Tramarin M; Rusconi L; Pizzamiglio L; Barbiero I; Peroni D; Scaramuzza L; Guilliams T; Cavalla D; Antonucci F; Kilstrup-Nielsen C
Hum Mol Genet; 2018 Jun; 27(12):2052-2063. PubMed ID: 29618004
[TBL] [Abstract][Full Text] [Related]
16. Pharmacotherapy with sertraline rescues brain development and behavior in a mouse model of CDKL5 deficiency disorder.
Fuchs C; Gennaccaro L; Ren E; Galvani G; Trazzi S; Medici G; Loi M; Conway E; Devinsky O; Rimondini R; Ciani E
Neuropharmacology; 2020 May; 167():107746. PubMed ID: 31469994
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK3β rescues hippocampal development and learning in a mouse model of CDKL5 disorder.
Fuchs C; Rimondini R; Viggiano R; Trazzi S; De Franceschi M; Bartesaghi R; Ciani E
Neurobiol Dis; 2015 Oct; 82():298-310. PubMed ID: 26143616
[TBL] [Abstract][Full Text] [Related]
18. Loss of CDKL5 impairs survival and dendritic growth of newborn neurons by altering AKT/GSK-3β signaling.
Fuchs C; Trazzi S; Torricella R; Viggiano R; De Franceschi M; Amendola E; Gross C; Calzà L; Bartesaghi R; Ciani E
Neurobiol Dis; 2014 Oct; 70(100):53-68. PubMed ID: 24952363
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of microglia overactivation restores neuronal survival in a mouse model of CDKL5 deficiency disorder.
Galvani G; Mottolese N; Gennaccaro L; Loi M; Medici G; Tassinari M; Fuchs C; Ciani E; Trazzi S
J Neuroinflammation; 2021 Jul; 18(1):155. PubMed ID: 34238328
[TBL] [Abstract][Full Text] [Related]
20. Dopaminergic loss of cyclin-dependent kinase-like 5 recapitulates methylphenidate-remediable hyperlocomotion in mouse model of CDKL5 deficiency disorder.
Jhang CL; Lee HY; Chen JC; Liao W
Hum Mol Genet; 2020 Aug; 29(14):2408-2419. PubMed ID: 32588892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
